Welcome to LookChem.com Sign In|Join Free

CAS

  • or

102308-97-4

Post Buying Request

102308-97-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

102308-97-4 Usage

Description

5-Amino-1-N-methylindole, with the chemical formula C9H10N2, is an indole derivative and a valuable building block in organic synthesis. It is characterized by a brown solid appearance and possesses a unique molecular structure that includes an amino group and a methylindole moiety. 5-AMINO-1-N-METHYLINDOLE is known for its role in the synthesis of various organic compounds, particularly in the copper-catalyzed synthesis of sulfonamides.

Uses

Used in Pharmaceutical Industry:
5-Amino-1-N-methylindole is used as a key intermediate in the synthesis of sulfonamides, which are a class of antimicrobial agents. These sulfonamides are employed as antibiotics to treat a wide range of bacterial infections, including urinary tract infections, respiratory infections, and skin infections. The copper-catalyzed synthesis of sulfonamides using 5-Amino-1-N-methylindole allows for the development of new and more effective antimicrobial agents.
Used in Organic Synthesis:
5-Amino-1-N-methylindole is used as a versatile building block in organic synthesis for the preparation of various organic compounds. Its unique molecular structure allows for the formation of a wide range of chemical reactions, enabling the synthesis of complex organic molecules with potential applications in various fields, such as pharmaceuticals, agrochemicals, and materials science.
Used in Research and Development:
5-Amino-1-N-methylindole is used as a research compound in the development of new synthetic methods and reaction pathways. Its reactivity and structural features make it an attractive candidate for exploring novel synthetic routes and understanding the underlying mechanisms of various chemical reactions. This research can lead to the discovery of new synthetic strategies and the development of more efficient and environmentally friendly processes in the field of organic chemistry.

Check Digit Verification of cas no

The CAS Registry Mumber 102308-97-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,2,3,0 and 8 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 102308-97:
(8*1)+(7*0)+(6*2)+(5*3)+(4*0)+(3*8)+(2*9)+(1*7)=84
84 % 10 = 4
So 102308-97-4 is a valid CAS Registry Number.
InChI:InChI=1/C9H10N2/c1-11-5-4-7-6-8(10)2-3-9(7)11/h2-6H,10H2,1H3

102308-97-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-Methyl-1H-indol-5-amine

1.2 Other means of identification

Product number -
Other names 5-Amino-1-N-Methylindole

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:102308-97-4 SDS

102308-97-4Relevant articles and documents

Novel anellated pyrazoloquinolin-3-ones: Synthesis and in vitro BZR activity

Ferlin, Maria Grazia,Chiarelotto, Gianfranco,Dall'Acqua, Stefano,MacIocco, Elisabetta,Mascia, Maria Paola,Pisu, Maria Giuseppina,Biggio, Giovanni

, p. 3531 - 3541 (2005)

A series of pyrazolo[4,3-c]pyrrolo[3,2-f]quinolin-3-one derivatives 6, 7a-c, 8a,b, 9a,b and 10-12 were synthesized as modified pyrazoloquinolinone analogs (PQs) and evaluated for their ability to inhibit radioligand to central and peripheral benzodiazepin

Discovery of N-(1-(3-fluorobenzoyl)-1H-indol-5-yl)pyrazine-2-carboxamide: a novel, selective, and competitive indole-based lead inhibitor for human monoamine oxidase B

Elkamhawy, Ahmed,Paik, Sora,Kim, Hyeon Jeong,Park, Jong-Hyun,Londhe, Ashwini M.,Lee, Kyeong,Pae, Ae Nim,Park, Ki Duk,Roh, Eun Joo

, p. 1568 - 1580 (2020)

Herein, two new series of N-substituted indole-based analogues were rationally designed, synthesized via microwave heating technology, and evaluated as noteworthy MAO-B potential inhibitors. Compared to the reported indazole-based hits VI and VII, compounds 4b and 4e exhibited higher inhibitory activities over MAO-B with IC50 values of 1.65 and 0.78?μM, respectively. When compared to the modest selectivity index of rasagiline (II, a well-known MAO-B inhibitor, SI > 50), both 4b and 4e also showed better selectivity indices (SI > 60 and 120, respectively). A further kinetic evaluation of the most potent derivative (4e) displayed a competitive mode of inhibition (inhibition constant (K i)/MAO-B = 94.52 nM). Reasonable explanations of the elicited biological activities were presented via SAR study and molecular docking simulation. Accordingly, the remarkable MAO-B inhibitory activity of 4e (N-(1-(3-fluorobenzoyl)-1H-indol-5-yl)pyrazine-2-carboxamide), with its selectivity and competitive inhibition, advocates its potential role as a promising lead worthy of further optimization.

Chemoselective transfer hydrogenation of nitroarenes by highly dispersed Ni-Co BMNPs

Zhang, Jia-Wei,Lu, Guo-Ping,Cai, Chun

, p. 25 - 29 (2016)

Highly dispread Ni-Co bimetallic nanoparticles (Ni-Co BMNPs) are synthesized and applied as an efficient catalyst in the chemoselective transfer hydrogenation of nitroarenes (CTH) using hydrazine hydrate as the hydrogen donor. The BMNPs can efficiently catalyze the reduction reaction without any additives under mild conditions with high TOF. Significantly higher activity is achieved when compared with corresponding single-component catalysts, optimal composition of the Ni-Co BMNPs was screened which was proved to be crucial in both the selectivity and yields. Excellent performance of Ni-Co BMNPs can be ascribed to the improved dispersion of active sites on the BMNPs surface (compared with Ni NPs) and the electron transfer from cobalt to nickel.

Direct C-H bond arylation: Selective palladium-catalyzed C2-arylation of N-substituted indoles

Lane, Benjamin S.,Sames, Dalibor

, p. 2897 - 2900 (2004)

(Equation Presented) We present a new, practical method by which N-substituted indoles may be selectively arylated in the C2-position with good yields, low catalyst loadings, and a high degree of functional group tolerance. Our investigation found that two competitive processes, namely, the desired cross-coupling and biphenyl formation, were operative in this reaction. A simple kinetic model was formulated that proved to be instructive and provided useful guidelines for reaction optimization; the approach described within may prove to be useful in other catalytic cross-coupling processes.

Method for preparing amine through catalytic reduction of nitro compound by cyclic (alkyl) (amino) carbene chromium complex

-

Paragraph 0015, (2021/04/17)

The cyclic (alkyl) (amino) carbene chromium complex is prepared from corresponding ligand salt, alkali and CrCl3 and used for catalyzing pinacol borane to reduce nitro compounds in an ether solvent under mild conditions to generate corresponding amine. The method for preparing amine has the advantages of cheap and accessible raw materials, mild reaction conditions, wide substrate application range, high selectivity and the like, and is simple to operate.

Novel heteroaryl amide derivatives as MAO-B inhibitors and pharmaceutical compositions for preventing, ameliorating or treating neurodegenerative diseases comprising the same

-

, (2021/04/06)

A novel heteroaryl amide derivative compound useful as MAO-B inhibitors. The present invention relates to a compound selected from a pharmaceutically acceptable salt thereof, a hydrate thereof, or a stereoisomer thereof, and a pharmaceutical composition comprising the compound as an active ingredient for preventing, alleviating, or treating neurodegenerative diseases such MAO as B's disease, 's disease, 's disease, and the like.

Triazolone compound with anti-fungal and anti-tumor effects and application

-

, (2021/07/17)

The invention discloses a triazolone compound with anti-fungal and anti-tumor effects. The structural general formula of the triazolone compound is shown in the specification, wherein the definition of each substituent group is detailed in the specification. The triazolone compound disclosed by the invention has anti-fungal and anti-tumor effects, can be used as a triazolone Hsp90 inhibitor and an Hsp90-HDAC double-target inhibitor, and can be used as an anti-fungal and anti-tumor drug.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 102308-97-4